随时了解来自 Accelagen 的最新消息

Filter by category
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Tag
Showing 0 of 100
Accelagen leads clinical trial for mRNA COVID-19 vaccine designed for immunosuppressed patients
Clinical development

Accelagen leads clinical trial for mRNA COVID-19 vaccine designed for immunosuppressed patients

Innovative biotech HelixNano has partnered with Accelagen to test the next generation of mRNA vaccines.
Read more
No items found.
Accelagen Fast Tracks First-in-Human Anti-BKV Therapy Trial
Clinical development

Accelagen Fast Tracks First-in-Human Anti-BKV Therapy Trial

When Swiss biotech sponsor Memo Therapeutics sought to trial a promising novel treatment for BK virus (Human polyomavirus 1), they turned to Accelagen.
Read more
No items found.
澳大利亚人受益于有史以来的首次癌症试验
Clinical development

澳大利亚人受益于有史以来的首次癌症试验

Accelagen 与 ImaginaB 合作开展开创性的 CD8 ImmunoPet 癌症试验，为免疫治疗患者提供组织活检的非侵入性替代方案
Read more
No items found.
与格里菲斯大学合作开展世界首例脊髓损伤治疗临床试验
All

与格里菲斯大学合作开展世界首例脊髓损伤治疗临床试验

Accelagen与格里菲斯大学合作开展了一项世界上第一个使用嗅觉细胞治疗脊髓损伤和恢复神经功能的试验。
Read more
No items found.
负面到正面：Accelagen如何将双重拒绝转化为成功的医疗技术，准备上市
Regulatory affairs

负面到正面：Accelagen如何将双重拒绝转化为成功的医疗技术，准备上市

Accelagen通过战略监管专业知识在两次拒绝后在42天内获得了美国医疗器械公司的道德批准。
Read more
No items found.
未找到任何结果。
没有符合此标准的结果。尝试更改搜索条件。

体验 Accelagen 的不同之处，开启人类健康的未来

取得联系